MENU
+Compare
BOLT
Stock ticker: NASDAQ
AS OF
Oct 3 closing price
Price
$5.31
Change
+$0.35 (+7.06%)
Capitalization
10.19M

BOLT Bolt Biotherapeutics Inc Forecast, Technical & Fundamental Analysis

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company... Show more

BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BOLT with price predictions
Oct 03, 2025

BOLT in upward trend: 10-day moving average crossed above 50-day moving average on October 01, 2025

The 10-day moving average for BOLT crossed bullishly above the 50-day moving average on October 01, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where BOLT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 03, 2025. You may want to consider a long position or call options on BOLT as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BOLT advanced for three days, in of 194 cases, the price rose further within the following month. The odds of a continued upward trend are .

BOLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 83 cases where BOLT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for BOLT turned negative on October 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

BOLT moved below its 50-day moving average on October 02, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOLT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.262) is normal, around the industry mean (23.241). P/E Ratio (0.000) is within average values for comparable stocks, (54.537). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.239). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.441) is also within normal values, averaging (354.169).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BOLT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
100
Web
https://www.boltbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STEC1.430.03
+1.87%
Santech Holdings Limited
VCYT36.000.37
+1.04%
Veracyte
SNCY11.900.06
+0.51%
Sun Country Airlines Holdings
PKG214.54-1.10
-0.51%
Packaging Corp
AMBO3.47-0.08
-2.25%
Ambow Education Holding Ltd

BOLT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with ATXS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+7.06%
ATXS - BOLT
35%
Loosely correlated
-2.21%
SYRE - BOLT
35%
Loosely correlated
-0.56%
XENE - BOLT
34%
Loosely correlated
+1.05%
BMRN - BOLT
33%
Loosely correlated
-0.25%
NRIX - BOLT
33%
Poorly correlated
+3.30%
More